Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation
Clinical trial NCT03518047 · COMPLETED
Trial details
- NCT number
- NCT03518047
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2020-02-11
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.